Table 1.
13C fractional enrichment of glutamate and glutamine in positions C4 and C3 for [2-13C]acetate, [1-13C]glucose, and [3-13C]lactate infusions in the human occipito-parietal lobe at the end of 2 h of infusions
[3-13C]Lactate | [1-13C]Glucose | [2-13C]Acetate | |
---|---|---|---|
fe[GluC4] | 6.7 ± 0.6 | 19.4 ± 1.2 | 5.4 ± 0.5 |
fe[GluC3] | 4.7 ± 0.4 | 14.7 ± 0.8 | 5.0 ± 0.5 |
fe[GlnC4] | 5.2 ± 0.6 | 16.7 ± 0.8 | 16.0 ± 2.4 |
fe[GlnC3] | 3.7 ± 0.4 | 12.0 ± 0.7 | 7.9 ± 1.0 |
fe[GlnC4]/fe[GluC4] | 0.78 ± 0.04 | 0.87 ± 0.04* | 2.90 ± 0.22** |
At the bottom line, the [4-13C]glutamine/[4-13C]glutamate labeling ratio is calculated for each individual experiment and averaged. Fractional enrichment values are in percentage, means ± SD, n = 9 for lactate group and n = 7 for the glucose and acetate group. The natural abundance (1.1%) is not subtracted.
Kolmogorov–Smirnov two-sample tests for difference between lactate and other groups: *p = 0.14 with glucose, and **p = 1 with acetate.